GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
T

Telix Pharmaceuticals TLX.AX · AUD

Health Care · ASX · 🇦🇺 Australia

Compare

13.93

+1.90%

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Analyst ratings

17 analysts, 1 Mar 2026. The analysts' own views, not ours.

  • 5Strong buy
  • 11Buy
  • 1Hold
  • 0Sell
  • 0Strong sell

Price targets

Brokers' own targets, 21 Feb 2026. Not our view.

Last close 13.93Average target 24.31

Low
17.17
Average
24.31
Median
23.15
High
35.70

Forecasts

Analyst averages for the fiscal years ahead

FY2026FY2027FY2028FY2029FY2030
Revenue$1.40bn$1.78bn$2.09bn$2.56bn$2.37bn
Revenue, highest$1.44bn$1.99bn$2.41bn$2.80bn$2.59bn
Revenue, lowest$1.38bn$1.69bn$1.93bn$2.46bn$2.27bn
Earnings per share0.110.060.311.661.13
Earnings per share, highest0.330.270.981.861.27
Earnings per share, lowest-0.07-0.230.061.571.07
Analysts139944

Earnings against forecasts

Earnings per share by fiscal quarter

Q2 2026Q4 2025Q2 2025Q4 2024Q2 2024Q4 2023
Forecast0.060.030.190.100.080.05
Reported0.15-0.010.240.040.060.04
Difference+140.4%-153.8%+21.6%-63.9%-29.6%-27.2%

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

2 / 10

Revenue growth 0.0% a year over 10 years. Return on equity -1.7%.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.